Benitec Biopharma Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Benitec Biopharma stock has a consensus rating of "Strong Buy" and an average price target of $24.17. The average 1-year stock price forecast is 87.66% higher than the current stock price, while the lowest is $16 (+24.22%) and the highest is $32 (+148.45%).

Price Target: $24.17 (+87.66%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$16	$24.17	$24.5	$32
Change	+24.22%	+87.66%	+90.22%	+148.45%

* Price targets were last updated on Jul 28, 2026.

Analyst Ratings

The average analyst rating for Benitec Biopharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	6	6	6	5	6	6
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	6	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yun Zhong Wedbush	Wedbush	Buy Initiates $16	Buy	Initiates	$16	+24.22%	Jul 28, 2026
Debjit Chattopadhyay Guggenheim	Guggenheim	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Jun 10, 2026
Ram Selvaraju H.C. Wainwright	H.C. Wainwright	Buy Reiterates $32	Buy	Reiterates	$32	+148.45%	May 26, 2026
Unknown Analyst Leerink Partners No rating	Leerink Partners	Buy Reiterates $18	Buy	Reiterates	$18	+39.75%	May 15, 2026
Ritu Baral TD Cowen	TD Cowen	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 15, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

18.22M

EPS This Year

-10.37

EPS Next Year

6.29

from -10.37

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026
Revenue	59.00K	73.00K	75.00K	-	-	-
Operating Income	-13.60M	-17.85M	-19.08M	-22.49M	-41.77M	-50.81M
Net Income	-13.88M	-18.21M	-19.56M	-21.75M	-37.92M	-46.39M
EPS	-	-	-	-	-	-10.37
Free Cash Flow	-7.28M	-8.72M	-10.19M	-11.68M	-11.46M	-35.66M
No. Analysts	-	-	-	-	-	6

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Chart

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

Chart

EPS	2026	2027	2028
High	-10.37
Avg	-10.37
Low	-10.37

EPS Growth

Chart

EPS Growth	2027	2028
High	-
Avg	-
Low	-